Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Telmisartan + Hydrochlorothiazide
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin receptor blockers
- ATC
- C09DA
- Strength
- 80 mg + 12.5 mg
- Dosage form
- Tablet
- Pack
- 14's
- Registration no.
- 109628
- Price record verified
- 2026-08-11
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 763.53 to 787.50 (+3.1%) between 1 Jul 2024 and 30 Jun 2026 · 2 official price records · pack 14's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Teli-H 80 80 mg + 12.5 mg, 14's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/teli-h-80-80-mg-12-5-mg-109628-14s-wilsons-pharmaceuticals/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 787.50 | 2026-06-30 | 2026-08-11 | DRAP PharmaPrice Index | Current |
| PKR 763.53 | 2024-07-01 | 2026-08-11 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 109628Price and registration data on this page were observed on 11 August 2026. Records change over time, so please cite the observation date alongside the access date.
